Evaluation of the presence and severity of menopausal symptoms among postmenopausal women screened for the metabolic syndrome

References

• Chedraui P, Pérez-López FR. Nutrition and health during mid-life: searching for solutions and meeting challenges for the aging population. Climacteric 2013;16:85–95
   PubMed Web of Science ®Google Scholar
• Fernández-Alonso AM, Cuadros JL, Chedraui P, et al. Obesity is related to increased menopausal symptoms among Spanish women. Menopause Int 2010;16:105–10
   PubMedGoogle Scholar
• Pérez-Roncero GR, Martínez-Dearth R, López-Baena MT, Ornat-Clemente L. Menopause-related symptoms in middle-aged women residing in the Zaragoza Province. Enferm Clin 2013;23:252–61
   PubMedGoogle Scholar
• Ornat L, Martínez-Dearth R, Chedraui P, Pérez-López FR. Assessment of subjective sleep disturbance and related factors during female mid-life with the Jenkins Sleep Scale. Maturitas 2014;77:344–50
   PubMed Web of Science ®Google Scholar
• Chedraui P, Pérez-López FR, Sánchez H, et al. Application of the 10-item Cervantes Scale among mid-aged Ecuadorian women for the assessment of menopausal symptoms. Maturitas 2014;79:100–5
   Google Scholar
• Grundy SM, Cleeman JI, Daniels SR, et al; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735–52
   PubMed Web of Science ®Google Scholar
• Lee SW, Jo HH, Kim MR, et al. Association between menopausal symptoms and metabolic syndrome in postmenopausal women. Arch Gynecol Obstet 2012;285:541–8
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Cannoletta M, Palma F, et al. Menopausal symptoms and risk factors for cardiovascular disease in postmenopause. Climacteric 2012;15:157–62
   PubMed Web of Science ®Google Scholar
• Pérez-Lopez FR, Chedraui P, Gilbert JJ, Pérez-Roncero G. Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women’s Health Initiative era. Fertil Steril 2009;64:1171–86
   Google Scholar
• Chedraui P, Escobar GS, Pérez-López FR, et al. Angiogenesis, inflammation and endothelial function in postmenopausal women screened for the metabolic syndrome. Maturitas 2014;77:370–4
   PubMed Web of Science ®Google Scholar
• Chedraui P, Pérez-López FR, San Miguel G, Avila C. Assessment of sexuality among middle aged women using the Female Sexual Function Index. Climacteric 2009;12:213–21
   PubMed Web of Science ®Google Scholar
• Brett KM, Chong Y. Hormone replacement therapy: knowledge and use in the United States. Hyattsville, MD: National Center for Health Statistics; 2001
   Google Scholar
• Blümel JE, Legorreta D, Chedraui P, et al; for the Collaborative Group for Research of the Climacteric in Latin America (REDLINC). Optimal waist circumference cutoff value for defining the metabolic syndrome in postmenopausal Latin American women. Menopause 2012;19:433–7
   PubMed Web of Science ®Google Scholar
• World Health Organization. Obesity and overweight. Fact sheet No 311. Available at: http://www.who.int/mediacentre/factsheets/fs311/en/index.html [last accessed 17 Jun 2012]
   Google Scholar
• Chedraui P, San Miguel G, Villacreses D, et al; Research Group for the Omega Women's Health Project. Assessment of insomnia and related risk factors in postmenopausal women screened for the metabolic syndrome. Maturitas 2013;74:154–9
   PubMed Web of Science ®Google Scholar
• Castelo-Branco C, Blumel JE, Roncagliolo ME, et al. Age, menopause and hormone replacement therapy influences on cardiovascular risk factors in a cohort of middle-aged Chilean women. Maturitas 2003;45:205–12
   PubMed Web of Science ®Google Scholar
• Heinemann K, Ruebig A, Potthoff P, et al. The Menopause Rating Scale (MRS) scale: a methodological review. Health Qual Life Outcomes 2004;2:45
   PubMedGoogle Scholar
• Menopause Rating Scale. Available from: http://www.menopause-rating-scale.info/documents/Ref_Values_CountrGr.pdf [last accessed 3 Jul 2014]
   Google Scholar
• Chedraui P, Aguirre W, Hidalgo L, Fayad L. Assessing menopausal symptoms among healthy middle aged women with the Menopause Rating Scale. Maturitas 2007;57:271–8
   PubMed Web of Science ®Google Scholar
• Aedo S, Porcile A, Irribarra C. Calidad de vida relacionada con el climaterio en una población Chilena de mujeres saludables. Rev Chil Obstet Ginecol 2006;71:402–9
   Google Scholar
• Zigmond AS, Snaith PR. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361–70
   PubMed Web of Science ®Google Scholar
• Hidalgo LA, Chedraui PA, Morocho N, et al. The metabolic syndrome among postmenopausal women in Ecuador. Gynecol Endocrinol 2006;22:447–54
   PubMed Web of Science ®Google Scholar
• Tziallas D, Kastanioti C, Kostapanos MS, et al. The impact of the metabolic syndrome on health-related quality of life: a cross-sectional study in Greece. Eur J Cardiovasc Nurs 2012;11:297–303
   PubMed Web of Science ®Google Scholar
• Okosun IS, Annor F, Esuneh F, Okoegwale EE. Metabolic syndrome and impaired health-related quality of life and in non-Hispanic White, non-Hispanic Blacks and Mexican-American Adults. Diabetes Metab Syndr 2013;7:154–60
   PubMedGoogle Scholar
• Loucks EB, Rehkopf DH, Thurston RC, Kawachi I. Socioeconomic disparities in metabolic syndrome differ by gender: evidence from NHANES III. Ann Epidemiol 2007;17:19–26
   PubMed Web of Science ®Google Scholar
• Berecki-Gisolf J, Begum N, Dobson AJ. Symptoms reported by women in midlife: menopausal transition or aging? Menopause 2009;16:1021–9
   PubMed Web of Science ®Google Scholar
• Royer M, Castelo-Branco C, Blumel JE, et al. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women. Climacteric 2007;10:164–70
   PubMed Web of Science ®Google Scholar
• Joffe H, Hall JE, Soares CN, et al. Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause 2002;9:392–8
   PubMed Web of Science ®Google Scholar
• Oppermann K, Fuchs SC, Donato G, et al. Physical, psychological, and menopause-related symptoms and minor psychiatric disorders in a community-based sample of Brazilian premenopausal, perimenopausal, and postmenopausal women. Menopause 2012;19:355–60
   PubMed Web of Science ®Google Scholar
• Blümel JE, Chedraui P, Baron G, et al. Menopause could be involved in the pathogenesis of muscle and joint aches in mid-aged women. Maturitas 2013;75:94–100
   PubMed Web of Science ®Google Scholar
• Dugan SA, Powell LH, Kravitz HM, et al. Musculoskeletal pain and menopausal status. Clin J Pain 2006;22:325–31
   PubMed Web of Science ®Google Scholar
• Rousseau ME, Gottlieb SF. Pain at Midlife. J Midwifery Womens Health 2004;49:529–38
   PubMed Web of Science ®Google Scholar
• Gao HL, Lin SQ, Wei Y, et al. The effect of age and menopausal status on musculoskeletal symptoms in Chinese women aged 35–64 years. Climacteric 2013;16:639–45
   PubMed Web of Science ®Google Scholar
• De Souza E Silva AV, Lacativa PG, Russo LA, et al. Association of back pain with hypovitaminosis d in postmenopausal women with low bone mass. BMC Musculoskelet Disord 2013;14:184
   PubMed Web of Science ®Google Scholar
• Bono G, Neri I, Granella F, et al. Factors associated with pain complaints in a clinical sample of postmenopausal women. J Psychosom Obstet Gynaecol 1995;16:117–21
   PubMed Web of Science ®Google Scholar
• Bay-Jensen AC, Slagboom E, Chen-An P, et al. Role of hormones in cartilage and joint metabolism: understanding an unhealthy metabolic phenotype in osteoarthritis. Menopause 2013;20:578–86
   PubMed Web of Science ®Google Scholar
• Chedraui P, Pérez-López FR, Escobar GS, et al.; Research Group for the Omega Women’s Health Project. Circulating leptin, resistin, adiponectin, visfatin, adipsin and ghrelin levels and insulin resistance in postmenopausal women with and without the metabolic syndrome. Maturitas 2014;79:86–90
   Google Scholar
• Llaneza P, García-Portilla MP, Llaneza-Suárez D, et al. Depressive disorders and the menopause transition. Maturitas 2012;71:120–30
   PubMed Web of Science ®Google Scholar
• Chedraui P, Pérez-López FR, Morales B, Hidalgo L. Depressive symptoms among climacteric women are related to menopausal symptom intensity and partner factors. Climacteric 2009;12:395–403
   PubMed Web of Science ®Google Scholar
• Zervas IM, Lambrinoudaki I, Spyropoulou AC, et al. Additive effect of depressed mood and vasomotor symptoms on postmenopausal insomnia. Menopause 2009;16:837–42
   PubMed Web of Science ®Google Scholar
• Vogelzangs N, Suthers K, Ferrucci L, et al. Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinology 2007;32:151–9
   PubMed Web of Science ®Google Scholar
• Raikkonen K, Matthews KA, Kuller LH. The relationship between psychological risk attributes and the metabolic syndrome in healthy women: antecedent or consequence? Metabolism 2002;51:1573–7
   PubMed Web of Science ®Google Scholar
• Silić A, Karlović D, Serretti A. Hypercortisolemic depression is associated with the metabolic syndrome in late-life. J Affect Disord 2012;141:72–8
   PubMed Web of Science ®Google Scholar
• Räikkönen K, Matthews KA, Kuller LH. Depressive symptoms and stressful life events predict metabolic syndrome among middle-aged women: a comparison of World Health Organization, Adult Treatment Panel III, and International Diabetes Foundation definitions. Diabetes Care 2007;30:872–7
   PubMed Web of Science ®Google Scholar